CUPR· Health Care› Medical Instruments & Supplies

Cuprina Holdings (Cayman) Limited Class A

Stage 4 · Declining · week 6

As of Oct 22, 2026, Cuprina Holdings (Cayman) is in Stage 4, the downtrend phase, now in week 6 (since Sep 15, 2026). It closed at $1.88, 77.6% below its 52-week high and below its 200-day average, which is falling.

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. More about the company

$1.88

-6.47% today

$13.2M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is CUPR early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2025-04-10 → 2026-10-22

S? 42w

S4 20w

S1 7w

2025-04-102026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S4 20w → S1 7w → S2 3w → S3 3w → S4 5w current

Total tracked: 80 weeks across 6 stage runs.

CUPR among Medical Instruments & Supplies44th of 51 by relative strength

All 51 →

Stocks in Medical Instruments & Supplies ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	PLSEPulse Biosciences, Inc	Stage 2 · wk 34	98	+1.3%
2	PDEXPro-Dex, Inc.	Stage 2 · wk 36	97	−13.3%
3	HBIOHarvard Bioscience, Inc.	Stage 2 · wk 11	95	+3.6%
4	ATRCAtriCure, Inc.	Stage 2 · wk 10	89	−1.1%
5	WSTWest Pharmaceutical Services, Inc.	Stage 2 · wk 24	82	+4.8%
6	BDXBecton, Dickinson and Company	Stage 2 · wk 11	81	+9.8%
7	ICUIICU Medical, Inc.	Stage 3 · wk 1	81	+3.1%
8	OSUROraSure Technologies, Inc.	Stage 3 · wk 8	75	−4.8%
…44	CUPRCuprina Holdings (Cayman) Limited Class A	Stage 4 · wk 6	13	0.0%

vs 52W High

-77.6%

$1.60 lo$8.41 hi

77.6% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 6

1w13w26w

Week 6, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-38.9%

200 DMA: $3.08 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

2.54x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+0.0%

-43.6%

-20.9%

YTD

-41.5%

-75.3%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S4

Wk 6 · Vol 2.54x

2026-10-21S4

Wk 6 · Vol 0.05x

2026-10-20S4

Wk 6 · Vol 0.09x

2026-10-19S4

Wk 5 · Vol 0.08x

2026-10-16S4

Wk 5 · Vol 3.16x

2026-10-15S4

Wk 5 · Vol 0.07x

2026-10-14S4

Wk 5 · Vol 0.13x

2026-10-13S4

Wk 5 · Vol 0.10x

2026-10-12S4

Wk 4 · Vol 0.50x

2026-10-09S4

Wk 4 · Vol 0.65x

2026-10-08S4

Wk 4 · Vol 0.13x

2026-10-07S4

Wk 4 · Vol 0.75x

Moving averages & range

50 DMA

$2.44

200 DMA

$3.08

52W High

$8.41

52W Low

$1.60

5D Low

$1.88

Resistance levels (recent highs)

20d High

$2.55

60d High

$3.58

120d High

$8.41

250d High

$8.41

Next resistance

+35.6%

to 20d High

ROE

-1569.1%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 1.3

Cuprina Holdings (Cayman): quick answers

What stage is Cuprina Holdings (Cayman) in?

As of Oct 22, 2026, Cuprina Holdings (Cayman) (CUPR) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 15, 2026 and is in week 6. What the four stages mean

Is Cuprina Holdings (Cayman) in an uptrend?

No. Cuprina Holdings (Cayman) is in a Stage 4 downtrend. It trades 38.9% below its 200-day average, which is falling.

How far is Cuprina Holdings (Cayman) from its 52-week high?

Cuprina Holdings (Cayman) closed at $1.88 on Oct 22, 2026, 77.6% below its 52-week high of $8.41. Its 52-week low is $1.60.

How has Cuprina Holdings (Cayman) performed over the past year?

As of Oct 22, 2026, Cuprina Holdings (Cayman) is down 75.3% over the past year and down 41.5% so far in 2026.

Which sector and industry is Cuprina Holdings (Cayman) in?

Cuprina Holdings (Cayman) is in the Medical Instruments & Supplies industry, part of the Health Care sector.

About this companyHealth Care· Medical Instruments & Supplies

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.